![](https://investorshub.advfn.com/uicon/430424.png?cb=1554906782)
Thursday, January 30, 2014 11:16:46 AM
For instance, while you suggested Linda's speech in San Francisco basically mimicked her Oppenheimer presentation; I, on the other hand, would take issue with that -- even allowing for your caveat. She also gave statistics regarding the compassionate use program Overall Survival and Progression Free Survival, she told us "glimpses" on Direct results were likely in the near term as well as the spring, summer and fall; she told us NWBO would start to draw upon the German Grant in the coming week(s) and she gave us the overall response rate for DCVAX-L in trials and compassionate use program (in addition to the German financial contribution/DCVAX prostate silence you already mentioned). I would certainly not use an adjective to describe you simply because you have a different take on this review.
I'm certain if you combed my posts you'd find that I violated this rule (aka. no negative adjectives) as well.
Regardless, compounding that by calling one "too sensitive," (another negative adjective for some), while apologizing, implies that you now view someone as an "overly sensitive pumper." These adjectives are unnecessary and tend to label and globalize a person who probably would not be described this way if he disappeared from this board in the manner John's friend did….may he rest in peace.
Negative adjectives may go by the wayside for the person distributing them, but they tend to cheapen the debate at hand -- and stick in the recipient's craw.
I highly suggest Wittgenstein's Poker: The Story of a Ten-Minute Argument Between Two Great Philosophers. I certainly do not mean that their debate tactics in any way resemble anyone on this board. I simply found it interesting and topical. IMHO
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM